Sign In

Search |

Add/Edit My Facility

MSKCC-Immune Monitoring Core Facility (Immune Function / Monitoring / Surveillance)

Subscribe to this Core


cite this facility

Primary Contact:

Phillip Wong

Facility RRID

RRID:SCR_027800

Facility Details

The Immune Monitoring Facility (IMF) provides translational research support for immune monitoring during cancer immunotherapy. Robust immune monitoring assays are essential for characterizing the immune status in patients receiving novel immune-modulating therapies, and the insights gained from studying the immune response in treated patients may help transition promising therapies from the clinical trial phase to standard of care. The IMF supports a variety of clinical research activities including standardized processing and cryopreservation of numerous clinical samples on a daily basis from patients on experimental cancer therapies, development and validation of immune monitoring assays, and correlative sample analysis using these assays to evaluate immune responses in patients enrolled in various immunotherapy trials. The facility utilizes highly specialized technologies to analyze both cellular and soluble protein biomarkers with the ultimate goal of identifying biomarkers that correlate with clinical responses which can then guide clinical decisions regarding the patients that may benefit most from specific immunotherapy regimens. Services and assays provided in the facility include, but are not limited to: (1) PBMC and serum/plasma isolation from human whole blood and sample cryopreservation; (2) Multiplex cytokine immunoassays; (3) Immunophenotypic analysis of immune cell subsets by multiparameter flow cytometry; (4) Evaluation of T cell antigen specificity and function by intracellular cytokine staining and ELISPOT assays.

Facility Policies

Services are offerred outside of

Consulting is offerred outside of Memorial Sloan Kettering Cancer Center

Last Updated: 03/23/2026